October 15, 2018 – Edmonton, Alberta, Canada - ATLAS GROWERS LTD. (“Atlas” or the “Company”), a wholly owned subsidiary of Atlas Biotechnologies Inc., is pleased to announce that it has received its Cultivation and Production licenses for its phase 1, 38,000 square foot production Facility from Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). With this licensing, Atlas will be able to produce dried cannabis, cannabis oil, cannabis resin, fresh cannabis, cannabis plants and cannabis seeds. Atlas’ purpose-built facility has an estimated production capacity of over 5,000 kg per year and utilizes cutting edge cultivation technology designed and overseen by esteemed Mr. Jim Hole, VP Cultivation for Atlas.
President & CEO Sheldon Croome states; “It’s a very exciting time for Atlas Growers. With the recent completion of the facility construction, our dedicated team is looking forward to executing its first cultivation cycle as well as commencing our planned genetics breeding and medical research programs.”
Atlas intends to start growing immediately and will be hosting a facility ribbon cutting ceremony in the coming weeks. Atlas invites interested parties to contact management for additional information on our initial facility and expansion plans.
About Atlas Growers Ltd.
Atlas is based in Edmonton, Alberta, Canada and is a wholly owned subsidiary of Atlas Biotechnologies Inc. Atlas’ initial purpose-built 38,000 square foot facility will have the capacity to produce approximately 5,000 kg of dried cannabis annually as well as to refine cannabis concentrates. Further, the 160-acre Atlas site could allow for significant future expansion of Atlas’ cultivation capacity and the Company has already received a development permit for up to 1,000,000 square feet of additional construction. Atlas is well financed and has a currently unutilized $6.25 million bank facility in place with ATB Financial.
For further information contact:
Jeffrey R. Gossain, P. Eng.
Vice President of Operations
Graeme Dick, BMgmt
Colwell Capital Corp.